Launching September 1, 2026. Join the waitlist
velri
Medications→Labs→Supplements→Find your path→Why Velri→Learn→Pricing→Where we serve→
Join the waitlist

Medications/NAD+ & energy

47 states · Cash-pay

NAD+

Billed at the pharmacy's cost, if prescribed
  • A cellular-energy coenzyme some adults explore with a clinician as part of a longevity and energy goal, if prescribed.
  • Compounded, not FDA approved.
Join the waitlist →

Velri opens September 1, 2026. A prescription is not guaranteed.

NAD+
NAD+ & energy
NAD+
FormInjectable vial or nasal spray, prepared by a compounding pharmacy. Compounded preparations are not FDA approved.
Dispensed byFilled and shipped by an independent licensed pharmacy, if prescribed.
Dosing1- or 3-month supply on a schedule your provider sets, if prescribed.
Compounded medications are not FDA approved.
Your goal
Built around your longevity and energy goal
Provider-guided
Labs reviewed
Most states
A prescription is not guaranteed. Care by independent, licensed providers.
Your path
How it works.
Share your goal
~2 min
Provider review
licensed
Pharmacy ships
if prescribed
Ongoing care
check-ins
Velri coordinates; care and dispensing are independent.
What it is
A cellular-energy coenzyme, prepared for you
ClassNAD+ coenzyme
Made bya licensed compounding pharmacy
QualityCompounded to your provider's order; not FDA approved.
Compounded medications are not FDA approved. No brand affiliation.
Details
  • GoalNAD+ & energy
  • FormInjectable vial or nasal spray
  • OptionsInjectable and nasal formulations; 1- and 3-month supply
  • AvailabilityAvailable in most states; varies by pharmacy.
  • CostThe pharmacy’s cost, billed separately if prescribed. Velri adds no markup.
What you pay
Velri membershipCoordination + support, billed by Velri$79/mo founding
NAD+Per order, if prescribed. Velri adds no markup.pharmacy cost
Provider consultationOne-time, paid to an independent Provider Groupbilled separately
Safety & disclosures

NAD+ given by infusion or injection commonly causes flushing, nausea, headache, and injection-site discomfort, and rapid infusions can cause chest tightness, cramping, or lightheadedness, which is why dosing rate matters. People who are pregnant, breastfeeding, or have significant heart, liver, or kidney conditions should review those with the prescribing provider before use. Long-term safety data for repeated NAD+ therapy is limited, so the risks of ongoing use are not fully established. Contact your provider promptly about chest tightness, severe flushing, or persistent nausea during or after a dose.

Compounded medications are not FDA approved. A prescription is required, is not guaranteed, and is determined by an independent, licensed provider based on your consultation. Velri is a non-clinical company; consultations and prescriptions are provided by independent, licensed medical groups, and medications are dispensed by independent, licensed pharmacies. Medication is priced at the pharmacy cost plus one flat Velri fulfillment fee, the same on every product. This page is for general information and is not medical advice.